Key studies that have changed the history and treatment of early HER2+ breast cancer: focus on individual therapy

Autor: I. V. Kolyadina, I. V. Poddubnaya

Publikováno v: Опухоли женской репродуктивной системы, Vol 16, Iss 3, Pp 46-56 (2021)

HER2-positive breast cancer is a unique subtype of the disease, not only in terms of aggressive biology, but also in terms of treatment options. Over the past 15 years, the strategy for treating early HER2-positive breast cancer has undergone a real

Externí odkaz: https://doaj.org/article/5dffac5ff44547f3b26d5cc0c6f2e57b

Carotid intima-media thickness and risk of atherosclerosis in multiple sclerosis: A cross-sectional study.

Autor: Najmi, Elyar Alizadeh^1,2 (AUTHOR), Mirzaasgari, Zahra^1,2,3,4 (AUTHOR), Motamed, Mohammad Reza^1,2 (AUTHOR), Aslani, Armin⁵ (AUTHOR) Aslard2014@gmail.com

Publikováno v: PLoS ONE. 11/19/2024, Vol. 19 Issue 11, p1-16. 16p.

Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.

Autor: Wysong, Ashley¹ (AUTHOR), Somani, Ally‐Khan^2,3 (AUTHOR), Ibrahim, Sherrif F.⁴ (AUTHOR), Cañueto, Javier^5,6,7 (AUTHOR), Fitzgerald, Alison L.⁸ (AUTHOR), Siegel, Jennifer J.⁸ (AUTHOR), Prasai, Anesh⁸ (AUTHOR), Goldberg, Matthew S.^8,9 (AUTHOR), Farberg, Aaron S.¹⁰ (AUTHOR), Regula, Christie¹¹ (AUTHOR), Bar, Anna¹² (AUTHOR), Kasprzak, Julia¹³ (AUTHOR), Brodland, David G.¹⁴ (AUTHOR), Koyfman, Shlomo A.¹⁵ (AUTHOR), Arron, Sarah T.¹⁶ (AUTHOR) saraharron@gmail.com

Publikováno v: Dermatology & Therapy. Mar2024, Vol. 14 Issue 3, p593-612. 20p.

Evaluating the Impact of Eat, Sleep, Console in Neonatal Abstinence Syndrome Treatment for Infants Exposed to Substance Use In Utero.

Autor: McGrath, Shannon V.¹ svbrown0629@email.campbell.edu, Rivera, Allie¹, Kennie-Richardson, Christopher¹, Ehrmann, David^2,3, Cline, Julie¹, Gable, Kaye², Forrest, Victoria¹

Publikováno v: Journal of Pediatric Pharmacology & Therapeutics. 2024, Vol. 29 Issue 2, p151-158. 8p.

A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)

Autor: Ang, Yvonne L. E.¹ (AUTHOR), Zhao, Xiaotian² (AUTHOR), Reungwetwattana, Thanyanan³ (AUTHOR), Cho, Byoung-Chul⁴ (AUTHOR), Liao, Bin-Chi^5,6 (AUTHOR), Yeung, Rebecca⁷ (AUTHOR), Loong, Herbert H.⁸ (AUTHOR), Kim, Dong-Wan⁹ (AUTHOR), Yang, James Chih-Hsin^5,6 (AUTHOR), Lim, Sun Min⁴ (AUTHOR), Ahn, Myung-Ju¹⁰ (AUTHOR) silkahn@skku.edu, Lee, Se-Hoon¹⁰ (AUTHOR) shlee119@skku.edu, Suwatanapongched, Thitiporn¹¹ (AUTHOR), Kongchauy, Kanchaporn¹² (AUTHOR), Ou, Qiuxiang² (AUTHOR), Yu, Ruoying² (AUTHOR), Tai, Bee Choo¹³ (AUTHOR), Goh, Boon Cher¹ (AUTHOR), Mok, Tony S. K.⁸ (AUTHOR), Soo, Ross A.¹ (AUTHOR) ross_soo@nuhs.edu.sg

Publikováno v: Cancers. Oct2023, Vol. 15 Issue 20, p4999. 16p.